Curaleaf Holdings, Inc.

Q2 FY2026 EarningsQ2 FY26 results significantly beat consensus across top and bottom lines. Revenue of $340.1M exceeded the $333.6M mean estimate, driven by 26% YoY growth in International segments and a 7% rebound in U.S. domestic sales. GAAP Net Income turned positive at $12.5M, a massive beat against the anticipated $50.7M loss, primarily due to a significant tax benefit. Adjusted EBITDA margin remained healthy at 20.6%, despite a slight YoY compression.